These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 35104159)

  • 1. Continuous Glucose Monitor Use Prevents Glycemic Deterioration in Insulin-Treated Patients with Type 2 Diabetes.
    Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R
    Diabetes Technol Ther; 2022 May; 24(5):332-337. PubMed ID: 35104159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
    Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R
    JAMA; 2021 Jun; 325(22):2273-2284. PubMed ID: 34077502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initiation of Continuous Glucose Monitoring Is Linked to Improved Glycemic Control and Fewer Clinical Events in Type 1 and Type 2 Diabetes in the Veterans Health Administration.
    Reaven PD; Newell M; Rivas S; Zhou X; Norman GJ; Zhou JJ
    Diabetes Care; 2023 Apr; 46(4):854-863. PubMed ID: 36807492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-time continuous glucose monitoring improves glycemic control and reduces hypoglycemia: Real-world data.
    Kant R; Antony MA; Geurkink D; Gilreath N; Chandra L; Zipprer E; Munir KM; Chandra R; Parker VG; Verma V
    Prim Care Diabetes; 2022 Dec; 16(6):786-790. PubMed ID: 36117090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond HbA1c.
    Bloomgarden Z
    J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Personal Continuous Glucose Monitoring Device Is Associated With Reduced Risk of Hypoglycemia in a 16-Week Clinical Trial of People With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion.
    Jensen MH; Vestergaard P; Hirsch IB; Hejlesen O
    J Diabetes Sci Technol; 2022 Jan; 16(1):106-112. PubMed ID: 32945187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of Hemoglobin A1c, Body Mass Index, and Rates of Severe Hypoglycemia in 4434 Adults with Type 1 or Type 2 Diabetes After Initiation of Continuous Glucose Monitoring.
    Lanzinger S; Best F; Bergmann T; Laimer M; Lipovsky B; Danne T; Zimny S; Bramlage P; Meyhöfer S; Holl RW
    Diabetes Technol Ther; 2022 Oct; 24(10):763-769. PubMed ID: 35653726
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Pratley RE; Kanapka LG; Rickels MR; Ahmann A; Aleppo G; Beck R; Bhargava A; Bode BW; Carlson A; Chaytor NS; Fox DS; Goland R; Hirsch IB; Kruger D; Kudva YC; Levy C; McGill JB; Peters A; Philipson L; Philis-Tsimikas A; Pop-Busui R; Shah VN; Thompson M; Vendrame F; Verdejo A; Weinstock RS; Young L; Miller KM;
    JAMA; 2020 Jun; 323(23):2397-2406. PubMed ID: 32543682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing the effectiveness of continuous subcutaneous insulin infusion with multiple daily insulin injection for patients with type 1 diabetes mellitus evaluated by retrospective continuous glucose monitoring: A real-world data analysis.
    Keyu G; Jiaqi L; Liyin Z; Jianan Y; Li F; Zhiyi D; Qin Z; Xia L; Lin Y; Zhiguang Z
    Front Public Health; 2022; 10():990281. PubMed ID: 36091534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
    Beck RW; Riddlesworth T; Ruedy K; Ahmann A; Bergenstal R; Haller S; Kollman C; Kruger D; McGill JB; Polonsky W; Toschi E; Wolpert H; Price D;
    JAMA; 2017 Jan; 317(4):371-378. PubMed ID: 28118453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials.
    Dicembrini I; Cosentino C; Monami M; Mannucci E; Pala L
    Acta Diabetol; 2021 Apr; 58(4):401-410. PubMed ID: 32789691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.
    Yeh HC; Brown TT; Maruthur N; Ranasinghe P; Berger Z; Suh YD; Wilson LM; Haberl EB; Brick J; Bass EB; Golden SH
    Ann Intern Med; 2012 Sep; 157(5):336-47. PubMed ID: 22777524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved Effectiveness of Immediate Continuous Glucose Monitoring in Hypoglycemia-Prone People with Type 1 Diabetes Compared with Hypoglycemia-Focused Psychoeducation Following a Previous Structured Education: A Randomized Controlled Trial.
    Serné EH; van den Berg IK; Racca C; van Raalte DH; Kramer MHH; de Wit M; Snoek FJ
    Diabetes Technol Ther; 2023 Jan; 25(1):50-61. PubMed ID: 36326825
    [No Abstract]   [Full Text] [Related]  

  • 14. Magnitude of Glycemic Improvement in Patients with Type 2 Diabetes Treated with Basal Insulin: Subgroup Analyses from the MOBILE Study.
    Davis G; Bailey R; Calhoun P; Price D; Beck RW
    Diabetes Technol Ther; 2022 May; 24(5):324-331. PubMed ID: 34962151
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Laffel LM; Kanapka LG; Beck RW; Bergamo K; Clements MA; Criego A; DeSalvo DJ; Goland R; Hood K; Liljenquist D; Messer LH; Monzavi R; Mouse TJ; Prahalad P; Sherr J; Simmons JH; Wadwa RP; Weinstock RS; Willi SM; Miller KM; ;
    JAMA; 2020 Jun; 323(23):2388-2396. PubMed ID: 32543683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 2 Diabetes and the Use of Real-Time Continuous Glucose Monitoring.
    Jackson MA; Ahmann A; Shah VN
    Diabetes Technol Ther; 2021 Mar; 23(S1):S27-S34. PubMed ID: 33534631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical Trial.
    Martens T; Beck RW; Bailey R; Ruedy KJ; Calhoun P; Peters AL; Pop-Busui R; Philis-Tsimikas A; Bao S; Umpierrez G; Davis G; Kruger D; Bhargava A; Young L; McGill JB; Aleppo G; Nguyen QT; Orozco I; Biggs W; Lucas KJ; Polonsky WH; Buse JB; Price D; Bergenstal RM;
    JAMA; 2021 Jun; 325(22):2262-2272. PubMed ID: 34077499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycemic Outcomes with Early Initiation of Continuous Glucose Monitoring System in Recently Diagnosed Patients with Type 1 Diabetes.
    Mulinacci G; Alonso GT; Snell-Bergeon JK; Shah VN
    Diabetes Technol Ther; 2019 Jan; 21(1):6-10. PubMed ID: 30575413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of Continuous Glucose Monitoring in Older Adults with Type 2 Diabetes Treated with Basal Insulin.
    Bao S; Bailey R; Calhoun P; Beck RW
    Diabetes Technol Ther; 2022 May; 24(5):299-306. PubMed ID: 34939824
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of continuous glucose monitoring-guided glycemic control on progression of coronary atherosclerosis in type 2 diabetic patients with coronary artery disease: The OPTIMAL randomized clinical trial.
    Kataoka Y; Kitahara S; Funabashi S; Makino H; Matsubara M; Matsuo M; Omura-Ohata Y; Koezuka R; Tochiya M; Tamanaha T; Tomita T; Honda-Kohmo K; Noguchi M; Maruki M; Kanai E; Murai K; Iwai T; Sawada K; Matama H; Honda S; Fujino M; Yoneda S; Takagi K; Otsuka F; Asaumi Y; Hosoda K; Nicholls SJ; Yasuda S; Noguchi T
    J Diabetes Complications; 2023 Oct; 37(10):108592. PubMed ID: 37741088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.